SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-052450
Filing Date
2022-08-31
Accepted
2022-08-31 07:50:47
Documents
17
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea165199-6k_immuron.htm 6-K 15019
2 IMC - APPENDIX 4E AND PRELIMINARY FINAL REPORT ea165199ex99-1_immuron.htm EX-99.1 1140074
3 IMC - FY22 RESULTS AND BUSINESS UPDATE PRESENTATION ea165199ex99-2_immuron.htm EX-99.2 23010
4 GRAPHIC image_001.jpg GRAPHIC 2744
5 GRAPHIC ex99-2_001.jpg GRAPHIC 98201
6 GRAPHIC ex99-2_002.jpg GRAPHIC 145721
7 GRAPHIC ex99-2_003.jpg GRAPHIC 149232
8 GRAPHIC ex99-2_004.jpg GRAPHIC 157219
9 GRAPHIC ex99-2_005.jpg GRAPHIC 125361
10 GRAPHIC ex99-2_006.jpg GRAPHIC 147310
11 GRAPHIC ex99-2_007.jpg GRAPHIC 125178
12 GRAPHIC ex99-2_008.jpg GRAPHIC 141544
13 GRAPHIC ex99-2_009.jpg GRAPHIC 99134
14 GRAPHIC ex99-2_010.jpg GRAPHIC 146203
15 GRAPHIC ex99-2_011.jpg GRAPHIC 135936
16 GRAPHIC ex99-2_012.jpg GRAPHIC 90369
17 GRAPHIC ex99-2_013.jpg GRAPHIC 183263
  Complete submission text file 0001213900-22-052450.txt   3587381
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 221216279
SIC: 2834 Pharmaceutical Preparations